Another study explored the anticolitic activity of thymol against the management of colitis, using a rat model treated with A.A. The colon mucosa of rats showed marked inhibition of histological damages, pro-inflammatory cytokines and elevation of protein (pNFκB p65) via down regulation of NF-κB pathway [113]. This evidence concerns the gene NFKB1 and colitis.